June 11, 2024 — Columbia University Irving Medical Center’s CUIMC Division of Cardiology has launched the Mitral and Tricuspid Center, an advanced clinical research center dedicated to leveraging the expertise of specialists from different cardiovascular disciplines to improve the diagnosis and treatment of all types of tricuspid and mitral valve conditions.

June 10, 2024 — Royal Philips, a global leader in health technology, announced that the first hospitals in Hong Kong have started using Philips real-time 3D Intracardiac Echocardiography (ICE) catheter – 

June 10, 2024 —  New expert consensus from the Society of Cardiovascular Computed Tomography (SCCT) reviews previously published qualitative and semi-quantitative measurements – including clinical guidelines like CAD-RADS 2.0 and disease classification scores such as the CT SYNTAX score for coronary revascularization – to create a comprehensive synopsis concerning quantitative CCTA methods.

June 10, 2024 — Atrium Health Sanger Heart & Vascular Institute has successfully completed the first commercial tricuspid clip procedure in the Carolinas, performed in May at Atrium Health Carolinas Medical Center. This achievement marks a significant milestone in the treatment of tricuspid regurgitation (TR), offering new hope to patients who are not candidates for traditional open-heart surgery.

June 7, 2024 — Access to thrombectomy should be expanded to include patients who experience basilar artery occlusion (BAO), a deadly type of emergent large vessel occlusion stroke, urges the Society of NeuroInterventional Surgery (SNIS).

June 7, 2024 — Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million patients globally with an annual mortality exceeding 100,000, and the numbers continue to rise. In CAVD, microcrystals of hydroxyapatite (a calcium phosphate mineral) deposit onto the heart valve leaflets and impair cardiac function. The disease has a dismal prognosis with most untreated patients dying two years after diagnosis. Currently, the only available treatment is surgical aortic valve replacement, which is not appropriate for all patients.

June 7, 2024 —  Medtronic today announced new data from the CoreValve Evolut Clinical Program, reinforcing the positive performance of the Evolut transcatheter aortic valve replacement (TAVR) System compared to surgical aortic valve repla

Stuart J. Connolly, MD

June 7, 2024 — It is with great sadness that the Diagnostic and Interventional Cardiology (DAIC) team has learned of the passing of arrhythmia medicine pioneer Stuart J. Connolly, MD, on June 2. 
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now